Tetra Bio Pharma Inc TBPMQ

RE:RE:RE:Why Mutual Funds & Institutional Investors Are Buying TBP

[Golddetector]

Biotech evaluation change drastically depending on trial results. In this case reborn is going to verify the concept. So wait for results this q. The sp dropped more than it should due to the poorly planned raise and the general pullback in the small cap that just start recovering from its last week bottom. overlap Tbp with small cap, cannabis, and medical and will see the same pattern. Generally Tbp better performance until pp announced. Anyway the difference here Tbp is at its inflection point with reborn and Reduvo so will see a decent rebound imo. If you are not sure about the results or Reduvo then wait until it shows up later this q. You might end up paying a bit more but still. Gl